Weekly Recap | Nike -3.51%, Mbappé signs with On
I'm LongbridgeAI, I can summarize articles.Nike fell 3.51% this week to close at $35.51, while the S&P 500 slipped just 0.08%, leaving the stock roughly 3.43 percentage points behind the benchmark. Monday (14 Sep) kicked off with a push toward the week’s high of $37.41, but the stock lost momentum from Tuesday, broke below $36 on Wednesday, briefly bounced on Thursday, then slid again on Friday (18 Sep) to a 52-week low of $35.50 before settling near the bottom of the range. Average daily volume of about 37.
The Week
Nike fell 3.51% this week to close at $35.51, while the S&P 500 slipped just 0.08%, leaving the stock roughly 3.43 percentage points behind the benchmark. Monday (14 Sep) kicked off with a push toward the week’s high of $37.41, but the stock lost momentum from Tuesday, broke below $36 on Wednesday, briefly bounced on Thursday, then slid again on Friday (18 Sep) to a 52-week low of $35.50 before settling near the bottom of the range. Average daily volume of about 37.7m shares ran roughly 64% above the 60-day median, pointing to heavier-than-usual turnover.
Key Events
The week’s news centred on Nike’s shifting roster of brand partners. On Tuesday (15 Sep), reports said Nike was nearing a deal to enter Formula 1 and rival Puma and Adidas; the stock hit a 52-week low the same day, helping drag the Dow lower. Thursday (17 Sep) brought two developments: Nike appointed LVMH executive Alexandre Arnault to its board, and it settled a patent dispute with Lululemon over the Mirror home-workout technology. On Friday (18 Sep), Swiss sportswear brand On confirmed it had signed French footballer Kylian Mbappé, a long-time Nike athlete, from Nike. The news pushed Nike further down while On’s shares rose. Nike is also due to report fiscal Q1 2027 earnings on 1 Oct, with UBS flagging deteriorating global sales trends during the week.
Analyst Ratings
Across 42 covering institutions, 9 rate the stock a buy, 1 an overweight, 26 a hold, 2 an underweight, and 3 a sell, with 1 at no opinion. The consensus rating is hold, with a consensus target of $48.21, about 35.8% above the latest price of $35.51. The target range is wide, from $23 at the low end to $94 at the high end, reflecting sharp disagreement about Nike’s outlook. Among eight peers in the footwear industry, Nike ranks first by rating.
The Week Ahead
The macro calendar is busy next week: Richmond Fed composite index on Tuesday (22 Sep), EIA crude and Cushing inventories on Wednesday (23 Sep), and jobless claims, current account balance, new home sales, and natural gas storage on Thursday (24 Sep). On the company side, Nike reports fiscal Q1 2027 results after the close on 1 Oct, with consensus estimates around $0.45 in EPS and $11.3b in revenue. After UBS’s warning on sales trends, that print will be the main test of whether fundamentals are stabilising.
In Short
Nike’s weak week lined up with a series of negative developments: Mbappé’s move to a rival, UBS’s target cut, and fresh doubts about sales momentum. Valuation sits at a relatively moderate ~17x P/E and ~3.5x P/B, while the Street’s stance is broadly neutral but split widely on price targets. On the latest trading day, large and medium orders were net buyers and small orders net sellers, so the capital picture is not yet one-sided. The focus now shifts to the 1 Oct earnings report and any flow effects from Nike’s removal from the S&P 100.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
